All Articles

Sam Altman is Backing This Blood Testing Startup

September 25, 2023
x min read

Blood tests in the future might be getting a whole lot faster.

What’s happening:

  • Toronto based startup Vital Biosciences is building diagnostics technology that aims to radically change blood testing
  • Their flagship product known as VitalOne is a small device that would enable doctors to be able to test and diagnose patients within twenty minutes of receiving their blood work
  • Vital has raised $48M in venture funding from the likes of Labcorp, Northpond Ventures, Route 66 Ventures, Sam Altman, Marc Benioff and others

Why it matters:

  • Currently it takes days to get results back from standard blood work for patients
  • Many important medical decisions and interventions rely on data from blood work
  • Blood work is one of the best ways to preventively detect major health complications such as diabetes or congestive heart failure

How it works:

  • With less than a teaspoon of blood as a sample, VitalOne aims to rapidly quantify the most commonly requisitioned test results in twenty minutes
  • This relies on technical breakthroughs in their device across biochemistry, robotics and computer vision

The fine print:

  • Silicon Valley has had an obsession with funding blood diagnostic startups in the past, including the rise and fall of Theranos
  • Vital Biosciences is still in late stage testing and their device is not yet for sale
  • Point of care testing for blood work is likely to require collaboration with the FDA to roll out hardware on a large scale

Discover what’s next. The world’s biggest ideas, disruptive trends, most exciting early stage companies and groundbreaking entrepreneurs.

By clicking Subscribe you're confirming that you agree with our Privacy Policy.
Thanks for subscribing!
Keep an eye out for a welcome email shortly.
Oops! Something went wrong while submitting the form.